학술논문
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
Document Type
Article
Author
Source
In World Allergy Organization Journal November 2022 15(11)
Subject
Language
ISSN
1939-4551